People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Space / Aerospace, Healthtech, Software / Tech, Other, Investment Vehicle, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Relativity Space, Inc. | — | Space / Aerospace | Growth/Late | $1.3B | $14.4B | 2019 |
| Outset Medical, Inc. | — | Healthtech | Series D+ | $395.4M | $36.2M | 2010 |
| Hippo Analytics Inc. | — | Software / Tech | Series D+ | $344.2M | $4.7B | 2019 |
| Vertice Pharma UK Parent Ltd | — | Other | Series D+ | $300.0M | $5.2B | 2015 |
| Helix Holdings I, LLC | — | Investment Vehicle | Series D+ | $235.0M | $764.9M | 2015 |
| ITC Nexus Holding Company, Inc. | — | Other Health Care | Series C | $191.8M | $353.7M | 2010 |
| Silk Road Medical Inc | — | Healthtech | Series C | $141.7M | $1.1B | 2011 |
| Constitution Medical Investors, Inc. | — | Biotechnology | Series B | $48.4M | $490.2M | 2010 |
| SBT Holdings Inc. | — | Other | Series A | $46.9M | $80.2M | 2012 |
Noah Knauf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Noah Knauf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Carney | 3 | 6 |
| Ruoxi Chen | 3 | 3 |
| Elizabeth Weatherman | 3 | 3 |
| Tony Chou | 2 | 7 |
| Elizabeth H. Weatherman | 2 | 6 |
| In Seon Hwang | 2 | 5 |
| Joseph Nemmers | 2 | 3 |
| Bess Weatherman | 2 | 2 |
| Annette Campbell-White | 1 | 11 |
| Arjun Sethi | 1 | 10 |
| Risa Stack | 1 | 9 |
| Sam Landman | 1 | 9 |
| James Thomas | 1 | 8 |
| Michael Baker | 1 | 8 |
| JEFF BIRD | 1 | 7 |
| John K. Bakewell | 1 | 7 |
| Adam Boyden | 1 | 7 |
| Jeffrey W. Bird | 1 | 6 |
| Jeffrey Bird | 1 | 5 |
| Jack Lasersohn | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.